Today: 29 April 2026
Browse Category

NYSE:CAH 30 October 2025 - 6 February 2026

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health shares fell 0.2% to $226.66 Friday morning, despite raising its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share after beating quarterly estimates. Second-quarter revenue rose 19% to $65.6 billion, with adjusted EPS at $2.63. CEO Jason Hollar cited strong specialty medicine demand but downplayed obesity drugs’ profit impact. Cencora rose 0.9%, McKesson slipped 0.4%.
6 February 2026
··
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health shares fell 2.64% to $199.71 on December 3, 2025, marking a fifth straight daily loss and leaving the stock 7% below its November 52-week high. The drop came despite gains in major indices. Recent filings show OMERS and Quantbot Technologies increased their stakes in the company. Cardinal Health has returned 74% over the past year.
4 December 2025
·
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health shares jumped 13% to record highs near $185 after fiscal Q1 2026 results beat estimates, with adjusted EPS at $2.55 and revenue at $64.0 billion. The company raised its full-year outlook and announced a $375 million buyback. All five segments grew profits, marking an eighth straight earnings beat. Cardinal plans to close the Solaris Health acquisition by early November.
30 October 2025
··

Stock Market Today

  • VICI Properties: Is the Stock Undervalued After Recent Recovery?
    April 29, 2026, 4:56 AM EDT. VICI Properties (VICI) trades near $28.65 after a recent share price rebound. Despite a modest 7.7% gain over the past month, the stock has declined 5.7% over the past year, trailing peers. A discounted cash flow (DCF) analysis suggests the stock could be undervalued by 45.7%, projecting intrinsic value at $52.73 per share based on adjusted funds from operations and future cash flows. VICI's price-to-earnings ratio stands at 11.03, below sector averages, reflecting cautious market sentiment amid concerns over income stability and tenant quality. Investors reassessing VICI's exposure to gaming real estate and sale-leaseback deals might find value in this discrepancy, though longer-term performance has been uneven.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 4:56 AM EDT VICI Properties: Is the Stock Undervalued After Recent Recovery? April 29, 2026, 4:56 AM EDT. VICI Properties (VICI) trades near $28.65 after a recent share price rebound. Despite a modest 7.7% gain over the past month, the stock has declined 5.7% over the past year, trailing peers. A discounted cash flow (DCF) analysis suggests the stock could be undervalued by 45.7%, projecting intrinsic value at $52.73 per share based on adjusted funds from operations and future cash flows. VICI's price-to-earnings ratio stands at 11.03, below
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop